Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions
- PMID: 38372149
- DOI: 10.1111/all.16064
Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions
Abstract
Tight junction (TJ) proteins establish a physical barrier between epithelial cells, playing a crucial role in maintaining tissue homeostasis by safeguarding host tissues against pathogens, allergens, antigens, irritants, etc. Recently, an increasing number of studies have demonstrated that abnormal expression of TJs plays an essential role in the development and progression of inflammatory airway diseases, including chronic obstructive pulmonary disease, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS) with or without nasal polyps. Among them, CRS with nasal polyps is a prevalent chronic inflammatory disease that affects the nasal cavity and paranasal sinuses, leading to a poor prognosis and significantly impacting patients' quality of life. Its pathogenesis primarily involves dysfunction of the nasal epithelial barrier, impaired mucociliary clearance, disordered immune response, and excessive tissue remodeling. Numerous studies have elucidated the pivotal role of TJs in both the pathogenesis and response to traditional therapies in CRS. We therefore to review and discuss potential factors contributing to impair and repair of TJs in the nasal epithelium based on their structure, function, and formation process.
Keywords: chronic rhinosinusitis; epithelial barrier theory; nasal epithelial cells; nasal polyps; tight junctions.
© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Similar articles
-
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.J Allergy Clin Immunol. 2012 Nov;130(5):1087-1096.e10. doi: 10.1016/j.jaci.2012.05.052. Epub 2012 Jul 26. J Allergy Clin Immunol. 2012. PMID: 22840853
-
Epithelial physical barrier defects in chronic rhinosinusitis.Expert Rev Clin Immunol. 2019 Jun;15(6):679-688. doi: 10.1080/1744666X.2019.1601556. Epub 2019 Apr 9. Expert Rev Clin Immunol. 2019. PMID: 30925220 Review.
-
The destruction of mucosal barriers, epithelial remodeling, and impaired mucociliary clearance: possible pathogenic mechanisms of Pseudomonas aeruginosa and Staphylococcus aureus in chronic rhinosinusitis.Cell Commun Signal. 2023 Oct 30;21(1):306. doi: 10.1186/s12964-023-01347-2. Cell Commun Signal. 2023. PMID: 37904180 Free PMC article. Review.
-
IL-17A disrupts the nasal mucosal epithelial barrier in patients with chronic rhinosinusitis by activating the ERK/STAT3 pathway.Rhinology. 2024 Dec 1;62(6):726-738. doi: 10.4193/Rhin24.127. Rhinology. 2024. PMID: 39365556
-
Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights.Front Immunol. 2021 May 21;12:663626. doi: 10.3389/fimmu.2021.663626. eCollection 2021. Front Immunol. 2021. PMID: 34093555 Free PMC article. Review.
Cited by
-
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps.Curr Allergy Asthma Rep. 2024 Dec 5;25(1):7. doi: 10.1007/s11882-024-01186-2. Curr Allergy Asthma Rep. 2024. PMID: 39636450 Review.
-
Small proline-rich protein 2A drives epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps via SAA2 upregulation.J Allergy Clin Immunol. 2025 May 28:S0091-6749(25)00578-0. doi: 10.1016/j.jaci.2025.05.012. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40447198
-
Changes in chronic rhinosinusitis: A retrospective analysis of computed tomography imaging and inflammatory changes either side of a 5-year interval.Biomed Rep. 2025 Jun 17;23(2):140. doi: 10.3892/br.2025.2018. eCollection 2025 Aug. Biomed Rep. 2025. PMID: 40589720 Free PMC article.
-
V Brazilian Consensus on Rhinitis - 2024.Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500. Epub 2024 Sep 7. Braz J Otorhinolaryngol. 2025. PMID: 39388827 Free PMC article. Review.
-
Advanced oral drug delivery systems for gastrointestinal targeted delivery: the design principles and foundations.J Nanobiotechnology. 2025 May 30;23(1):400. doi: 10.1186/s12951-025-03479-8. J Nanobiotechnology. 2025. PMID: 40448152 Free PMC article. Review.
References
REFERENCES
-
- Yii ACA, Tay TR, Choo XN, Koh MSY, Tee AKH, Wang DY. Precision medicine in united airways disease: a "treatable traits" approach. Allergy. 2018;73(10):1964‐1978. doi:10.1111/all.13496
-
- Eguiluz‐Gracia I, Mathioudakis AG, Bartel S, et al. The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma. Allergy. 2020;75(9):2170‐2184. doi:10.1111/all.14177
-
- Saito K, Orimo K, Kubo T, et al. Laundry detergents and surfactants‐induced eosinophilic airway inflammation by increasing IL‐33 expression and activating ILC2s. Allergy. 2023;78(7):1878‐1892. doi:10.1111/all.15762
-
- Guan WJ, Peng Y, Zi XX, et al. Motile ciliary disorders in chronic airway inflammatory diseases: critical target for interventions. Curr Allergy Asthma Rep. 2018;18(9):48. doi:10.1007/s11882-018-0802-x
-
- Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73(5):993‐1002. doi:10.1111/all.13373
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources